• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep Med . SARS-CoV-2 infection exacerbates the cellular pathology of Parkinson's disease in human dopaminergic neurons and a mouse model

tetano

Editor, Senior Moderator
Cell Rep Med


. 2024 May 10:101570.
doi: 10.1016/j.xcrm.2024.101570. Online ahead of print. SARS-CoV-2 infection exacerbates the cellular pathology of Parkinson's disease in human dopaminergic neurons and a mouse model

Bina Lee[SUP] 1 [/SUP], Ha Nyeoung Choi[SUP] 2 [/SUP], Young Hyun Che[SUP] 3 [/SUP], Myungjun Ko[SUP] 4 [/SUP], Hye Min Seong[SUP] 5 [/SUP], Min Gi Jo[SUP] 6 [/SUP], Seon-Hee Kim[SUP] 1 [/SUP], Chieun Song[SUP] 5 [/SUP], Subeen Yoon[SUP] 3 [/SUP], Jiwoo Choi[SUP] 3 [/SUP], Jeong Hee Kim[SUP] 3 [/SUP], Minkyeong Kim[SUP] 7 [/SUP], Min Young Lee[SUP] 8 [/SUP], Sang Won Park[SUP] 2 [/SUP], Hye Jung Kim[SUP] 2 [/SUP], Seong Jae Kim[SUP] 5 [/SUP], Do Sik Moon[SUP] 9 [/SUP], Sun Lee[SUP] 10 [/SUP], Jae-Hoon Park[SUP] 11 [/SUP], Seung-Geun Yeo[SUP] 12 [/SUP], Richard G Everson[SUP] 4 [/SUP], Young Jin Kim[SUP] 2 [/SUP], Kyung-Wook Hong[SUP] 13 [/SUP], In-Soon Roh[SUP] 14 [/SUP], Kwang-Soo Lyoo[SUP] 15 [/SUP], Yong Jun Kim[SUP] 16 [/SUP], Seung Pil Yun[SUP] 17 [/SUP]



Affiliations
Abstract

While an association between Parkinson's disease (PD) and viral infections has been recognized, the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on PD progression remains unclear. Here, we demonstrate that SARS-CoV-2 infection heightens the risk of PD using human embryonic stem cell (hESC)-derived dopaminergic (DA) neurons and a human angiotensin-converting enzyme 2 (hACE2) transgenic (Tg) mouse model. Our findings reveal that SARS-CoV-2 infection exacerbates PD susceptibility and cellular toxicity in DA neurons pre-treated with human preformed fibrils (hPFFs). Additionally, nasally delivered SARS-CoV-2 infects DA neurons in hACE2 Tg mice, aggravating the damage initiated by hPFFs. Mice infected with SARS-CoV-2 display persisting neuroinflammation even after the virus is no longer detectable in the brain. A comprehensive analysis suggests that the inflammatory response mediated by astrocytes and microglia could contribute to increased PD susceptibility associated with SARS-CoV-2. These findings advance our understanding of the potential long-term effects of SARS-CoV-2 infection on the progression of PD.

Keywords: COVID-19 sequalae; DA neuron; PD; Parkinson’s disease; SARS-CoV-2; disease modeling; dopaminergic neuron; hACE2 transgenic mouse; neuroinflammation; neurological sequelae.

 
Back
Top Bottom